Eddie Hickman Score: 59
Analyst at
Guggenheim
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+32.7%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
86%
6 W / 1 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
100%
2 W / 0 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
50%
1 W / 1 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 2 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
86%
6 W / 1 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
86%
6 W / 1 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 |
Tarsus Pharmaceuticals Inc
TARS
|
BUY |
$89.00
Est. +58%
|
$56.25 | $58.84 |
Pending
|
$57.56
+2.3%
|
| Jun 10, 2026 |
Zevra Therapeutics Inc
ZVRA
|
BUY |
$29.00
Est. +112%
|
$13.66 | $15.02 |
Pending
|
$12.14
-11.1%
|
| May 08, 2026 |
Zevra Therapeutics Inc
ZVRA
|
BUY |
$25.00
Est. +127%
|
$11.00 | $15.02 |
Pending
|
$12.14
+10.4%
|
| Mar 10, 2026 |
Zevra Therapeutics Inc
ZVRA
|
BUY |
$23.00
Est. +109%
|
$11.03 | $15.02 |
Pending
|
$12.14
+10.1%
|
| Mar 10, 2026 |
GH Research PLC
GHRS
|
BUY |
$34.00
Est. +115%
|
$15.81 | $31.00 |
Pending
|
$28.58
+80.8%
|
| Jan 05, 2026 |
GH Research PLC
GHRS
|
BUY |
$29.00
Est. +84%
|
$15.80 | $31.00 |
Target Met
|
$28.58
+80.9%
|
| May 02, 2025 |
Tarsus Pharmaceuticals Inc
TARS
|
BUY |
$84.00
Est. +77%
|
$47.36 | $85.25 |
Precision Hit (±3%)
|
$57.56
+21.5%
|
Tarsus Pharmaceuticals Inc
TARS
Jul 21, 2026
Signal & Target
BUY
$89.00
Start Price
$56.25
Best Price (1Y)
$58.84
Current Price
$57.56
Return
+2.3%
Zevra Therapeutics Inc
ZVRA
Jun 10, 2026
Signal & Target
BUY
$29.00
Start Price
$13.66
Best Price (1Y)
$15.02
Current Price
$12.14
Return
-11.1%
Zevra Therapeutics Inc
ZVRA
May 08, 2026
Signal & Target
BUY
$25.00
Start Price
$11.00
Best Price (1Y)
$15.02
Current Price
$12.14
Return
+10.4%
Zevra Therapeutics Inc
ZVRA
Mar 10, 2026
Signal & Target
BUY
$23.00
Start Price
$11.03
Best Price (1Y)
$15.02
Current Price
$12.14
Return
+10.1%
GH Research PLC
GHRS
Mar 10, 2026
Signal & Target
BUY
$34.00
Start Price
$15.81
Best Price (1Y)
$31.00
Current Price
$28.58
Return
+80.8%
GH Research PLC
GHRS
Jan 05, 2026
Signal & Target
BUY
$29.00
Start Price
$15.80
Best Price (1Y)
$31.00
Current Price
$28.58
Return
+80.9%
Tarsus Pharmaceuticals Inc
TARS
May 02, 2025
Signal & Target
BUY
$84.00
Start Price
$47.36
Best Price (1Y)
$85.25
Current Price
$57.56
Return
+21.5%